Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
chlorhydrate de procaïnamide 100 mg/mL, ampoule de 10 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
|
Procainamide hydrochloride 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
|
Procainamide hydrochloride 375 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
|
Procainamide hydrochloride 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely procainamide hydrochloride 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
|
Procainamide hydrochloride 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
|
Procainamide hydrochloride 1000mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
|
Procainamide hydrochloride 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
|
Procainamide hydrochloride 250mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
|
Procainamide hydrochloride 750mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
|
Procainamide hydrochloride 500mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
|
Procainamide hydrochloride 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Procainamide hydrochloride 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Procainamide hydrochloride 375 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Procainamide hydrochloride 375 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Procainamide hydrochloride 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Procainamide hydrochloride 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely procainamide hydrochloride 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely procainamide hydrochloride 500 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Procainamide hydrochloride 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Procainamide hydrochloride 250 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Procainamide hydrochloride 750mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
|
Procainamide hydrochloride 250mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Procainamide hydrochloride |
Inferred relationship |
Some |
|
Procainamide hydrochloride 500 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Procainamide hydrochloride 500 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely procainamide hydrochloride 1 gram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely procainamide hydrochloride 1 gram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Procainamide hydrochloride 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Procainamide hydrochloride 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely procainamide hydrochloride 500 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Procainamide hydrochloride 250 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |
Procainamide hydrochloride 375 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Procainamide hydrochloride |
Inferred relationship |
Some |
1 |